Evidence map›Paper›PMID 39618629›Full record

ArticleCureus2024

Investigating the Efficacy of Regenerative Therapy With Autogenous Platelet-Rich Plasma in Vertical Bone Defects.

Tsvetalina Gerova-Vatsova

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Tsvetalina Gerova-VatsovaPeriodontology and Dental Implantology, Medical University of Varna, Varna, BGR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Context and objective The main goal of periodontal therapy is to remove periodontopathogenic microorganisms and regenerate destructured periodontal tissues. Advances in biomaterials have improved the results of regenerative procedures. However, there is limited data available to determine the best material for vertical bone deformities treated with regenerative treatment. Studies on autogenous platelet-rich plasma (PRP) have been conducted, but it is often combined with other biomaterials. The objective of this study is to examine the exact efficacy of solely administering autogenous PRP in regenerative therapy of vertical bone defects. Materials and methods The study was conducted from August 2022 to July 2023 at the Faculty of Dental Medicine, Medical University Varna, BGR, using the University Medical and Dental Center as its base. It includes 12 cases with bipartite, tripartite, or a combination of the listed vertical bone defects. Participating patients met the following criteria: signed informed consent; age between 18 and 65 years; individuals in good health without diagnosed systemic disease, and adequate dental care. The clinical parameters investigated and recorded immediately before regenerative therapy with autogenous PRP and six months after the surgical intervention were probing depth, margo gingivalis level, clinical attachment level, and cone beam computed tomography (CBCT)-indicators A (the distance from the cemento-enamel junction to the bottom of the bone defect), B (the distance from the cemento-enamel junction to the apex of the bone defect), and C (the width of the defect). The results obtained from the measurements immediately before the regenerative therapy with PRP and six months after the surgical intervention were compared and analyzed.  Results and conclusions The clinical outcomes for vertical bone defects at the six-month mark following the PRP therapy showed an average 3.83 mm reduction in probing depth, an average 0.08 mm coronal migration of the gingival margin, and an average 3.92 mm gain of the clinical level of attachment. The CBCT showed bone filling, which is supported by the average decrease for points A, B, and C of 1.69 mm, 0.51 mm, and 0.36 mm, respectively. The study's findings primarily illustrate the strong potential of autogenous PRP as an independently applicable substance for regeneration therapy in periodontology.

Indexed as

biomaterialsperiodontal pocketplatelet-rich plasmaregenerative therapyvertical bone defect

Identifiers

PMID39618629
PMCPMC11605669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.